DVT Expert Witnesses in Oregon

This highly qualified engineer earned his BS and MS in mechanical engineering from California Polytechnic State University. He went on to earn his PhD in mechanical engineering from the University of California, Berkeley. He has over 10 years of experience conducting failure analysis for various products including biomedical devices. He formerly served as Principal Mechanical Engineer at COR Innovations, Inc., a biomedical device start-up. In this role, he was responsible for designing multiple functioning prototypes and designing and fabricating numerous electromechanical bench top apparatus' for materials testing and validation. He went on to serve as Senior Staff R&D Engineer at Abbott Vascular Structural Heart, where his primary role was serving as technical lead for improvements in their MitraClip device. He currently serves as Chief Technology Officer and co-founder of a medical device company that is focused on treating vaginal atrophy in breast cancer survivors and post-menopausal women through a novel and hormone-free, energy based therapy.

This highly qualified expert earned his MD and completed his Internal Medicine residency at the University of California San Francisco. He completed his fellowship in Medical Oncology at Stanford University. He is board certified by the American Board of Internal Medicine/Medical Oncology. He is a member of prestigious association and societies such as the American Association for Cancer Research, the American Society of Clinical Oncology, the American Society of Hematology, the American College of Surgeons Oncology Group. He has been the recipient of such prestigious awards such as the Meritorious Research Award from the Oncology Division at Stanford University and the Rose Award for Exemplary Clinical Care from Oregon Health & Science University. This expert has published over 20 peer-reviewed journal articles. He is the former Hematology and Medical Oncology Fellowship Training Program at the Oregon Health & Science University and currently serves as Section Chief of the Solid Tumors, Hematology and Medical Oncology Division at a major university.